Suzhou Pharma Services

suzhoupharma.com

Suzhou Pharma Services, a division of Amerigen Pharmaceuticals, is a contract development and manufacturing organization focused on oral solid dose forms. With US offices located in East Brunswick, NJ and the primary manufacturing site located in Suzhou, China, we are licensed by the Chinese sFDA and the US FDA. The management team in China and the USA is comprised of highly experienced, Western trained leaders, averaging 20+ years experience with multi-national branded and generic pharmaceutical companies.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CITIUS PHARMACEUTICALS ACHIEVES CHEMICAL MANUFACTURING AND CONTROL MILESTONES FOR MINO-LOK

Citius Pharmaceuticals | September 23, 2020

news image

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has achieved a number of significant milestones over the past several weeks for Mino-Lok®. Mino-Lok is an antibiotic lock solution being developed as an adjunctive therapy for patients with central line-associated bloodstream infections (CLABSIs) or catheter-related bloods...

Read More

Business Insights

SUVODA AND N-SIDE ANNOUNCE AGREEMENT TO DELIVER INTEGRATED CLINICAL TRIAL OPTIMIZATION AND IRT SOLUTIONS FOR REAL-TIME DEMAND PLANNING

Suvoda LLC | May 13, 2022

news image

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system, and rare disease, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources.  To date, the two companies have successfully partnered on more than 100 clinical ...

Read More

NELSON PHARMACY FINED $344,000 AND DIRECTOR $50,000 FOR PRICE-FIXING

Miragenews | June 07, 2020

news image

The Wellington High Court has ordered Prices Pharmacy 2011 Limited and a director of the company, Stuart Hebberd, to pay fines of $344,000 and $50,000 respectively, after they admitted engaging in price-fixing in breach of the Commerce Act. The Commission filed proceedings in April 2018 alleging that Prices Pharmacy 2011 Limited and its directors facilitated a price-fixing arrangement with competing Nelson pharmacies in May 2016, in breach of Part 2 of the Commerce Act. In most cases, the arrang...

Read More

Business Insights

HOVIONE EXPANDS DRUG PRODUCT OFFERING WITH A NEW MANUFACTURING LINE DEDICATED TO CONTINUOUS TABLETING

Hovione | September 07, 2022

news image

Hovione, the leader in spray drying and particle engineering, announced that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to support Hovione's commitment to providing access and services for continuous tableting, Hovione has further strengthened its capabilities by establishing a highly experienced multi-disciplinary global team in continuous table...

Read More
news image

CITIUS PHARMACEUTICALS ACHIEVES CHEMICAL MANUFACTURING AND CONTROL MILESTONES FOR MINO-LOK

Citius Pharmaceuticals | September 23, 2020

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has achieved a number of significant milestones over the past several weeks for Mino-Lok®. Mino-Lok is an antibiotic lock solution being developed as an adjunctive therapy for patients with central line-associated bloodstream infections (CLABSIs) or catheter-related bloods...

Read More
news image

Business Insights

SUVODA AND N-SIDE ANNOUNCE AGREEMENT TO DELIVER INTEGRATED CLINICAL TRIAL OPTIMIZATION AND IRT SOLUTIONS FOR REAL-TIME DEMAND PLANNING

Suvoda LLC | May 13, 2022

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas such as oncology, central nervous system, and rare disease, today announced they have entered into an agreement to partner with N-SIDE — a deeptech company that empowers organizations in the clinical trials industry to make better decisions and optimize the use of critical resources.  To date, the two companies have successfully partnered on more than 100 clinical ...

Read More
news image

NELSON PHARMACY FINED $344,000 AND DIRECTOR $50,000 FOR PRICE-FIXING

Miragenews | June 07, 2020

The Wellington High Court has ordered Prices Pharmacy 2011 Limited and a director of the company, Stuart Hebberd, to pay fines of $344,000 and $50,000 respectively, after they admitted engaging in price-fixing in breach of the Commerce Act. The Commission filed proceedings in April 2018 alleging that Prices Pharmacy 2011 Limited and its directors facilitated a price-fixing arrangement with competing Nelson pharmacies in May 2016, in breach of Part 2 of the Commerce Act. In most cases, the arrang...

Read More
news image

Business Insights

HOVIONE EXPANDS DRUG PRODUCT OFFERING WITH A NEW MANUFACTURING LINE DEDICATED TO CONTINUOUS TABLETING

Hovione | September 07, 2022

Hovione, the leader in spray drying and particle engineering, announced that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to support Hovione's commitment to providing access and services for continuous tableting, Hovione has further strengthened its capabilities by establishing a highly experienced multi-disciplinary global team in continuous table...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us